Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Move comes amid rising regulatory pressures
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Targets high-growth eye care expansion push
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
Subscribe To Our Newsletter & Stay Updated
